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New copper complexes, [Cu(phen)2(Thy)]2Cl and [Cu(phen)2(Ad)]2Cl (phen = 
1,10-phenantroline, Ad (Adenine, a purine nucleobase) and Thy (Thymine, a 
pyrimidine nucleobase)), were synthesized and characterized by atomic 
absorption spectroscopy (AAS), conductivity measurement, UV-visible and 
infrared (IR) techniques. The complexes were tested for their antimicrobial 
activity against two gram positive and two gram negative bacterial strains. The 
results of in vitro antimicrobial activities were compared with the commercially 
available antimicrobial agents (ciprofloxacin and chloramphenicol). This 
comparative study has demonstrated that [Cu(phen)2(Thy)]2Cl inhibited the 
growth of  methicillin resistant Staphylococcus aureous (MRSA), Escherichia coli 
(E. coli) and Klebsiella pneumoniae (K. pneumonia) better than chloramphenicol 
by 11.25%, 19.41% and 25.35%, respectively. It also showed better activities 
than ciprofloxacine on MRSA and K. pneumoniae by 2.50% and 12.13%, 
respectively. Similarly, [Cu(phen)2(Ad)]2Cl demonstrated better inhibitions than 
chloramphenicol against MRSA, E. coli and K. pneumoniae by 11.24%, 2.48% and 
9.06%,  respectively. Therefore, after in vivo cytotoxicity investigations, these 
complexes could be considered as potential antimicrobial agents. 
 
 
                 © 2017 International Scientific Organization: All rights reserved. 
Capsule Summary: Copper complexes i.e., [Cu(phen)2(Thy)]2Cl and [Cu(phen)2(Ad)]2Cl were synthesized and characterized  
along with antimicrobial acivities evaluation. In comparison to standard antimicrobial agents, the synthesized complexes 
showed promising  antimicrobial acivities. 
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INTRODUCTION 
 
The rapid increase in the number of multidrug-resistant 
bacteria is fast becoming a global concern (Henderson, 
2006).  Thus, the discovery of novel active compounds 
against new targets is a matter of urgency. The conventional 
approach to address this impulse employing materials 
originating from wild growing material have shortened the 
life span of the sources. This problem has  magnetized 
attention of the scientific community in general to consider 
and investigate transition metal compolexes as alternative 
solutions for this problem(Bruijnincx and  Sadler, 2009; Vela 
et al., 2011; Mishra et al., 2012; Suntharalingam et al., 2013, 
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Patil et al. 2015). From this perspective, so many studies have 
been done on the syntheis, structure, chemical properties and 
antimicrobial activity of several metal complexes (Rafique et 
al., 2010; Motswainyana and Ajibade, 2015).  The study 
results demonstrated the therapeutic and diagnostic 
properties of transition metal complexes which have 
attracted considerable attention, leading to their application 
in many areas of modern medicine. In this regard,  they 
served as anticancer (Clair et al., 2016), antinfection agents 
(Mukherjee et al., 2013) and anti-inflammatory (Weder et al., 
2002). These outcomes encouraged the researchers to fine 
tune the properties and actions of the metal complexes by 
coordinating the metal ions with a variety of ligands (Rafique 
et al., 2010; Buchtik et al., 2011; Devi and  Batra, 2015; 
Motswainyana and Ajibade, 2015). This is because; the 
ligands have the ability to tune on the chemical properties of 
metal ions (Sears et al., 2010; Wilkins, 1974). This include 
stabilization of different oxidation states[Boyer et al., 2010) 
and modulation of the solvophilicity, electrophilic and 
nucleophilic properties of the metal (Goo et al., 2015; 
Tolman, 1977). 
Copper is one of the metals acting as an essential 
trace element involved in cellular respiration, antioxidant 
defense, neurotransmission, connective tissue biosynthesis 
and cellular iron metabolism (Babu et al., 2007; Culotta, 
2010). Moreover, several investigations provide evidence 
that copper ions are capable of interacting directly with 
nuclear proteins and DNA, causing site-specific damage 
(Kang et al., 2004, Gou et al., 2015). In addition, it has been 
reported that copper compounds delay cell-cycle progression 
and increase cell death in different cell cultures (Paul et al., 
2014). Copper (II) ions binding to specific sites can modify 
conformation of proteins, polynucleotides, or membranes. Cu 
(II) binds to DNA with high degree of affinity and thus 
promotes DNA oxidation (Chaviara et al., 2005; Marzano et 
al., 2006; Marzano et al., 2009). From this perspective copper 
(II) complexes have become the targets in addressing certain 
cancer problems (Gou et al., 2015).  In this regard,  complexes 
of copper containing  1, 10-phenanthroline (phen) as a ligand 
mixed with other types of ligands stirred great interests since 
they exhibit numerous biological activities such as antitumor, 
antibacterail (Zoroddu et al., 1996), and anti-candida activity 
(Ranford, 1993).  
1,10-phenanthroline has a rigid framework and 
possesses a superb ability to chelate many metal ions via its 
two nitrogen centers. The resulting complexes show 
potential for various applications due to their high charge 
transfer mobility, among other attractive properties (He et 
al., 2009). Although a number of copper (II) complexes 
containing phenanthroline mixed with other ligands 
previously appeared in the literature (Dede et al., 2009; 
Jennifer and  Muthiah, 2014; Ganeshpandian et al., 2014; 
Rajarajeswari et al., 2014), there is still a gap to design and 
study new ones. In view of the importance of such complexes, 
we describe here the synthesis, characterizations and the 
biological (antibacterial) activities of mixed-ligand complexes 
of Cu (II) containing 1,10-phenantroline adenine (Ad) and 
thymine (Thy) (purine and pyrimidine nucleobases, 
respectively). The purpose of this investigation is to let 
adenine and thymine  get coordinated with the metal ion 
through their Lewis basic nitrogen to form three dimentional 
regid structure. Consequently, the complexes present the 
adenine and thymine along with 1, 10-phenanthroline so that 
the counter nucleobase residue of the genetic material in 
microbes recognizes and interacts in a certain fashion. The 
latter phenomenon ultimately is expected to result in strong 
antimicrobial activity of the complex. 
 
MATERIAL AND METHODS 
Chemical, reagents and instrumnation  
All the chemicals used were either of analytical grade or 
chemically pure grade. The electronic absorption spectra 
were measured using Sanyo SP65 UV/VIS 
Spectrophotometer in the 200-800 nm regions. IR data were 
obtained using AVATAR 330 FT-IR, Thermo Nicolet 
spectrophotometer in the range of 4000-400 cm-1.  
Quantitative analysis of copper ion content of the sample 
complex was determined using Analytik Jena nov AA300 
model atomic absorption spectrophotometer. The melting 
point of each complex was determined by STONE, 
STAFFORDSHIRE, ST15 OSA, UK digital melting   point 
apparatus. The conductance of each complex was measured 
by JENWAY 4200 conductivity meter at room temperature.  
Synthesis of the metal complexes 
Synthesis of [Cu(Phen)2(H2O)]2Cl: [Cu(Phen)2(H2O)]2Cl was 
prepared by adding dropwise a solution of 1,10-
phenanthroline monohydrate (2 gm, 10 mmol) in 30 mL of 
methanol to a solution of CuCl2 .2H2O (0.87 gm, 5 mmol) in 30 
mL of methanol while stirring magnetically at room 
temperature. A greenish blue homogeneous solution was 
obtained (Yield: 2.08 gm (80.3%)).     
Synthesis of [Cu(Phen)2(Ad)]2Cl and [Cu(Phen)2(Thy)]2Cl: 
[Cu(phen)2(H2O)]2Cl (0.624 gm,1mmol) was dissolved in 50 
mL distilled water. Being magnetacally stirred in an oil bath a 
hot solution of  adenine (1 mmol)  in 50 mL distilled water 
was slowly added.  The mixture was  refluxed for 6 hours at 
80°C. Green homogeneous solution was obtained. The solvent 
was removed in vacuum and medium see green  powder was 
collected. Finally, the complex was washed with methanol 
three times and dried in vacuum desiccator over anhydrous 
CaCl2. The purity of the metal complexes was checked by TLC 
(Yield: 0.573 gm, 74.7%). 
Synthesis of [Cu(Phen)2(H2O)(Thy)]2Cl: To a solution of 
[Cu(phen)2(H2O)2]Cl2 (0.624 gm,1mmol)  in 50 mL distilled 
water in  250 mL double necked round bottomed flask 
magnetically stirred in oil bath a hot solution of  thymine 
(0.148 gm, 1 mmol) in 50 mL distilled water was slowly 
added drop wise from burette and the reaction mxture was  
refluxed for 5 hours at 80 0C. A green homogeneous solution 
was formed. The solvent was removed using rotary 
evaporator and spring green fine powder was collected and 
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washed. The complexes kept in desiccators until use. Yield: 
0.589 gm (83.1%). The strategy of the synthesis is indicated 
in Scheme 1. 
Antibacterial activity testing 
The in vitro antibacterial activity of the salt, ligands and 
complexes were tested using Agar diffusion method. 
Microorganisms used in this study were two strains of gram-
positive: (Staphylococcus aureous and Methicillin Resistant 
Staphylococcus aureous (clinical isolate)) and two strains of 
gram-negative  (Escherichia coli (ATCC255922), and Klebsiela 
pneumoniae (ATCC986605)). These bacterial strains 
were maintained in the appropriate blood agar base at 4 0C 
until use. Antibiotic discs (Ciprofloxacin 5 µg, 
Chloramphenicol 30 µg) were used as reference. The 
minimum inhibitory concentration against each bacterium 
was determined by preparing aqueous solutions of different 
concentrations of the complexes (200 μg/ml, 300 μg/ml, 400 
μg/ml, 500 μg/ml, 600 μg/ml, 800 μg/ml and 1 mg/ml). The 
antibacterial tests were carried out at the Amhara Regional 
Health Research Laboratory Center, Bahir Dar, Ethiopia. 
 
RESULTS AND DISCUSSION 
Characterization of the metal complexes 
The complexes are colored and stable in air. They are 
insoluble in common organic solvents but soluble in 
ethanol, methanol and DMSO. Also highly soluble in water. 
The appearance, melting poins, elemental estimation, yield 
and molar conductivity data of all the complexes are shown 
in Table 1.  
Molar conductance of the metal complexes 
The conductance measurements, recorded for 10−3M 
solutions of the metal complexes in water listed in Table 1 
provides information about the presence of two chloride 
ions per copper ion which supports the chloride estimation 
expirment result. The data shows that all the complexes are 
1:2 electrolytes (Bard et al., 1980). However, the molar 
conductance shows a slight decreasing order as the molar 
mass of the cation is increasing as the mobility decreases. 
This is because the speed of the mobility of the cations as 
the result of the kinetic energy imparted by the electric 
field from measurement instrument changes in a 
 
Scheme 1: Synthesis path of the complexes 
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decreasing order [Cu(phen)2(H2O)]2Cl, [Cu(phen)2(Ad)]2Cl, 
[Cu(phen)2(Thy)]2Cl, follwoing the increasing molecular 
mass(Atkins, 1994). This phenomenon is a strong evidence 
for the coordination of the ligands to the metal. 
Infrared spectra of the complexes 
Important characteristic IR bands of the ligands and all Cu 
(II) Complexes are given in Table 2. The IR spectra of the 
complexes (Figure 1) demonstrate that all the ligands are 
coordinated to the metal. The characteristic ν(C=C) (1627 cm-
1) of free phenanthroline remains unchanged in 
[Cu(phen)2(H2O)]Cl2 and down shifted in 
[Cu(phen)2(Ad)]2Cl to 1600 cm-1, in [Cu(phen)2(Thy)]2Cl to 
1623 cm-1 indicating electron cloud is expanded to the 
nucleobases (adenine and thymine). However, its 
characteristic ν(C=N) (1588 cm-1 ) in its free form is down 
shifted (to 1582 cm-1, 1569 and 1520 cm-1) indicating the 
decrease in the bond order of C=N when coordinated to 
Cu(II).  
The characteristic doublate ν(NH2) (3297 cm-1 and 
3120 cm-1) of adenine are also observed in 
[Cu(phen)2(Ad)]Cl being up shifted to 3310 cm-1 and 3122 
cm-1 indicating adenine is coordinated through the primary 
amine (-NH2) rather than through its ring (NH). This fact is 
supported by the nearly unchanged frequency appearance 
of its characteristic ring ν(NH) at 3356 cm-1.   
 
Fig. 1: IR spectra of a) 1, 10-Phenanthroline, b) Adenine, c) Thymine, d) [Cu(phen)2(H2O)]2Cl, e) [Cu(phen)2(Ad)]2Cl 
and f)[Cu(phen)2(Thy)]2Cl 
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The existence of thymine in the complexes is also bestowed 
by its two characteristic ring ν(N3H) (3356 cm-1 ) signaled 
being obsecured with ν(OH) of coordinated water and  ν(N1H) 
(3198 cm-1) up shifted to 3209 cm-1. This confirms that 
thymine is coordinated to Cu(II) through its N1H( Scheme 
1). In addition to this, the coordination of  thymine is 
confirmed by its other characteristic ν(CH)(CH3) (2933 cm-
1) and  ν(C=O) (1735 cm-1 )  which appeared at 2932 cm-1 in 
[Cu(phen)2(Thy)]2Cl and 1739 cm-1 in both complexes, 
respectively.  
 
Electronic spectra of the complexes 
 
The electronic spectra of the ligands and complexes are 
displayed in Table 3. The coordination of the ligands to the 
metal is demonstrated by the shifts in the maximum 
absorption wave lengths corresponding to ligand centered 
π→π*(C=C), π→π*(C=N), n→π*(C=N) as well as metal 
centered energy states 2B1g →2A1g and 2B1g→ 2B2g 
transitions.  
 
Fig. 2: UV spectra of a) CuCl2.2H2O, b)[Cu(phen)2(H2O)]2Cl, c)[Cu(phen)2(Ad)]2Cl and d) [Cu(phen)2(Thy)]2Cl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Gram-negative bacteria(E. Coli & K. Pneumoniae) 
              
Gram-positive bacteria(MRSA & S. Aureus)       
Fig. 3: Biological Activity of copper salt, Ligands, Cu(II) 
complexes and reference antibiotic 
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In [Cu(Phen)2(H2O)2]Cl2,  the absorptions occurred at 294 
nm, 644 nm  and  626 nm are assigned for  π→π*(C=N), 2B1g 
→2A1g, and 2B1g→ 2B2g transitions,  respectively. This 
increase in the absorption wave length compared to the salt 
may be due to the increase in the axial  Cu-OH2 bond length 
following the formation of  shorter and stronger equatorial 
Cu-N bonds with the strong field phenanthroline.  
Consequently, the energy gap between dz2 and dxy orbitals 
is decreased which narrows the gap between 2B2g and 2A1g 
energy states (Housecroft and  Sharpe, 2005; Missler and  
Tarr,  2004). Up on  coordination of adenine, 
[Cu(phen)2(Ad)]2Cl,  the absorptions are shifted to 297 nm, 
677 nm and 664 nm, respectively. This further increase in 
the maximum absorption wave lenthes is due to the further 
increase in the axial Cu-N bond with adenine due to steric 
reasons (Scheme 1) further decreases the gap between dz2 
and dxy that decreases the energy gap between 2B2g and 2A1g 
energy states more than the case of [Cu(Phen)2(H2O)]2Cl. In 
[Cu(phen)2(Thy)]2Cl, the absorption wave lengthes are 
blue shifted by 9 and 10 nm to 296 nm, 668 nm and 654 nm 
Table 1: Appearance, melting point, elemental estimation, molar conductivity data of the metal complexes 
 
Complex  
(color) 
 
Melting point 
(0C) 
 
Yield (%) 
Elemental estimation 
( %) 
ΛM (S cm2 mol-1) 
Cu Cl 
 
[Cu(phen)2(H2O)]2Cl 
(Medium spring 
green) 
 
325-327 
 
80.3 
 
12.84 (12.57) 
 
14.36(14.24) 
 
138.46 
[Cu(phen)2(Ad)]2Cl 
(Medium see green) 
246 
 
74.3. 
 
10.09 (9.98) 11.28(11.18) 126.08 
[Cu(phen)2(Thy)]2Cl 
(Spring green) 
253 
 
83.1 
 
10.23(9.98) 11.14(10.96) 124.23 
 
Table 2: Characteristic infra-red frequencies of the ligands and their complexes with Cu(II) (cm−1) 
Ligands/ 
complexes 
ν(OH)(H2O) 
cm-1 
ν(NH2)  
cm-1 
ν(NH) 
cm-1 
(ring) 
ν (CH)(CH3)  
cm-1 
 
ν(CH) (C-=C) 
cm-1 
ν (C=C) 
cm-1 
ν (C=N) 
cm-1 
ν (C-N)  
cm-1 
ν (C=O) 
cm-1 
 
1, 10-
phenanthroline  
hydrate 
 
3424 
    
3041 
 
1627 
 
1588 
 -  
Adenine  3297, 
3120 
3356  2972 1667 1511 1254, 
1331 
 
Thymine  - 3356,  
3198 
2933 3070 1677  1214 1735 
[Cu(phen)2(H2O)]2
Cl 
3355 -   3050 1627 1582 1306  
[Cu(phen)2 
(Ad)]2Cl 
3362 3310, 
3122 
3352 - 3048,  
2976 
1600, 
1673 
1569, 
1520  
1303, 
1252 
 
[Cu(phen)2 
(Thy)]Cl 
3376 - 3209 2932 3056 1623 
1681 
- 1237 1739 
 
Table 3:  Electronic spectra of the ligands and the complexes 
Complexes Band position, λmax (nm) Assignments 
CuCl2.2H2O 292, 569 , 551 LMCT* , 2B1g →2A1g, and 2B1g→ 2B2g 
[Cu(Phen)2(H2O)]2Cl 294, 644, 626 (π→π*(C=N), 2B1g →2A1g, and 2B1g→ 2B2g 
[Cu(Phen)2(Ad)]2Cl 297, 677, 664 (π→π*(C=N), 2B1g →2A1g, and 2B1g→ 2B2g 
[Cu(Phen)2(Thy)]2Cl 296, 668, 654 π→π*(C=O), 2B1g →2A1g, and 2B1g→ 2B2g 
*LMCT=Ligand to metal charge transfer 
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compared with [Cu(phen)2(Ad)]2Cl. This is because of the 
formation of axial shorter and stronger Cu-N with thymine 
where N is in  the ring which is influenced by the π-system 
which gives it π-acidity. On the basis of the data, square 
pyramidal geometries have been proposed for all 
complexes. 
 
Screening for antibacterial activity of the ligands and 
their copper complexes 
 
Antimicrobial acitivity of the ligands and their complexes 
were investigated against  two gram positive (Methicilin 
resistant S. aureus and S. aureus) and two gram negative 
bacteria (E. coli and K. pneumoniae) on Mueller-Hinton 
agar, by well-diffusion method using water and methanol as 
solvents. 
Water and methanol exhibited no activity against 
all of the bacteria tested. The free 1,10-phenanthroline 
showed the highest antibacterial activities among the freee 
ligands. Due to its planarity and extended conjugation, 1, 
10-phenanthroline is able to intercalate with double 
strands of the DNA  and forming  π-π interactions with base 
pairs of  DNA (Table 4, Figure 3). However, thymine and 
adenine showed no antibacterial activity againest the tested 
bacteria. The metal salt, CuCl2.2H2O, showed no effect with 
the  exception of  E. coli with (20 ± 0.82 mm inhibition zone 
(Figure 3).  
 In general, the complexes are all active against the 
tested bacteria showing a range of  inhibition zone 18-30 
mm (Table 4). [Cu(phen)2(Ad)]2Cl demonstrated higher 
activity than chloramphenicol against Methicilin resistant S. 
aureus,  E.coli and K.  pneumoniae. [Cu(phen)2(Thy)]2Cl 
showed higher activity than chloramphenicol against 
Methicilin resistant S. aureus and E.  coli and greater than 
chloramphenicol and ciprofloxacin against K.  pneumoniae.  
The percent activity indexes of the compounds against the 
reference antibiotics demonstrated significant comparative 
activity (Table 5). It can be obsereved that these 
compounds are potential candidates in inhibiting  
K.pneumoniae compared to ciprofloxacine (Table 5a). 
Moreover, they inhibited  MRSA, E. Coli and K.pneumoniae 
much better than chloramphenicol (Table 5b). 
 
Minimum inhibitory concentration (MIC)  
 
Table 4: Antibacterial activity of metal salt, ligands, metal complexes and reference antibiotics 
Compound 
tested 
Antimicrobial activity ( mean IZ diameter(mm) ± SD) 
S.  aureus MRSA E.  coli K.  pneumoniae 
1 0 ± 0 0 ± 0 20.00 ± 0.82 0 ± 0 
2 24.33±0.47 23.67 ± 0.47 23.00 ± 0.82 18.33 ± 0.94 
3 22.00 ± 0 26.00 ± 0.82 27.00 ± 0.47 18.33  ± 0.47 
4 21.00 ± 0.82 26.67 ± 0.47 32.67± 0.47 22.00  ± 0.82 
5 20.00  ± 0.82 28.67 ± 0.47 29.67 ± 0.47 28.33  ±0.94 
6 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
7 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
8 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
9 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
S1 26.67 ± 0.94 26.00 ± 0.82 34.67 ± 0.94 19.33  ± 0.47 
S2 25.67 ± 1.25 23.67 ± 0.47 26.33 ± 0.94 16.67  ± 0.47 
MRSA= Methicilin resistant S. Aureus, IZ = inhibition zone. SD = Standard deviation, 1 = CuCl2.2H2O, 2 = [Cu(phen)2(H2O)]2Cl, 3 = 
[Cu(phen)2(Ad)]2Cl, 4 = [Cu(phen)2(Thy)]2Cl, 5 = 1,10-phenantroline, 6= adenine, 7 = thymine, 8 = methanol, 9 = distilled water, 
S1 = Ciprofloxacin,  S2 = Chloramphenicol. 
 
Table 5: The activity (%) index data of the complexes against the tested microbes compared to:  a) ciprofloxacine, b) 
chloramphenicol 
Compounds S. aureus MRSA E. coli K.pneumoniae 
  
 
(A) 
  
[Cu(phen)2(Thy)]2Cl 78.74 102.57 94.23 113.81 
[Cu(phen)2(Ad)]2Cl 82.49 100 77.88 94.83 
  
(B) 
  
[Cu(phen)2(Thy)]2Cl 81.81 112.67 124.08 131.97 
[Cu(phen)2(Ad)]2Cl 87.7 109.84 102.54 109.96 
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[Cu(Phen)2(Ad)]2Cl shows high antibacterial activity on the 
tested bacterial strains  except for K. pneumoniae with a 
MIC value of  300 μg/mL  to 1 mg/mL . When diluted to 200 
μg/mL it shows activity against E. coli and S. aureus. Below 
100 μg/mL bacterial strains it showed no observable 
growth (Table 6). 
[Cu(Phen)2(Thy)]2Cl showed significant 
antibacterial activity on tested bacterial pathogens  except 
for K. pneumoniae with a MIC value of  200 μg/mL  to 1 
mg/mL. When diluted to 200 μg/mL it showed activity 
against Methicilin resistant S. aureus and S. aureus. 
However, below 100 μg/mL   [Cu(Phen)2(Thy)]2Cl bacterial 
growth was observed (Table 7). 
 
CONCLUSIONS 
 
Two new Copper-mixed ligand complexes of copper(II) 
containing 1,10-phenanthroline, adenine and  thymine as 
ligands have been synthesized and characterized by 
elemental analysis using atomic absorption spectroscopy 
and chloride estimation  to determine the amount of copper 
and chlorine, respectively.   IR and visible spectroscopy 
analyses were employed to confirm the coordination.  
Conductance measurements were also used to determine 
the iconicity of the complexes. All of these investigations 
showed that two 1, 10-phenantroline and one adenine 
molecules are coordinated to the first complex. In the 
second complex, two 1, 10-phenanthroline and one thymine 
molecules are coordinated. In all cases, two chloride ions 
are found as counter anions.  Antimicrobial studies of these 
complexes against four bacteria show that there is 
increased activity of the metal ions upon coordination to 
these ligands. It is speculated that, after in vivo 
experiments, these complexes could be considered as 
potential drugs to prevent the multiplication of all of the 
four bacteria. 
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